Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
São Paulo med. j ; 141(1): 20-29, Jan.-Feb. 2023. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1424651

ABSTRACT

ABSTRACT BACKGROUND: Syphilis is a major public health issue worldwide. In people living with human immunodeficiency virus (PLHIV), there are higher incidences of both syphilis and neurosyphilis. The criteria for referring PLHIV with syphilis for lumbar puncture is controversial, and the diagnosis of neurosyphilis is challenging. OBJECTIVE: To describe the knowledge, attitudes, and practices of infectious disease specialists and residents in the context of care for asymptomatic HIV-syphilis coinfection using close-ended questions and case vignettes. DESIGN AND SETTING: Cross-sectional study conducted in three public health institutions in São Paulo (SP), Brazil. METHODS: In this cross-sectional study, we invited infectious disease specialists and residents at three academic healthcare institutions to answer a self-completion questionnaire available online or in paper form. RESULTS: Of 98 participants, only 23.5% provided answers that were in line with the current Brazilian recommendation. Most participants believed that the criteria for lumbar puncture should be extended for people living with HIV with low CD4+ cell counts (52.0%); in addition, participants also believed that late latent syphilis (29.6%) and Venereal Disease Research Laboratory (VDRL) titers ≥ 1:32 (22.4%) should be conditions for lumbar puncture in PLHIV with no neurologic symptoms. CONCLUSION: This study highlights heterogeneities in the clinical management of HIV-syphilis coinfection. Most infectious disease specialists still consider syphilis stage, VDRL titers and CD4+ cell counts as important parameters when deciding which patients need lumbar puncture for investigating neurosyphilis.

2.
Article in English | LILACS-Express | LILACS | ID: biblio-1422785

ABSTRACT

ABSTRACT Vaccination coverage has been dropping in Brazil and other countries. In addition, immune responses after vaccination may not be homogeneous, varying according to sociodemographic and clinical factors. Understanding the determinants of incomplete vaccination and negative antibody test results may contribute to the development of strategies to improve vaccination effectiveness. In this study, we aimed to investigate the frequency of vaccine adherence, factors associated with incomplete vaccination for measles, mumps, rubella (MMR) and hepatitis A, and factors associated with the seronegative test results for measles, mumps and hepatitis A at 2 years of age. This was a population-based cohort that addressed health conditions and mother/infant nutrition in Cruzeiro do Sul city, Brazil. Vaccination data were obtained from official certificates of immunization. The children underwent blood collection at the two-year-old follow-up visit; the samples were analyzed using commercially available kits to measure seropositivity for measles, mumps, and hepatitis A. We used modified Poisson regression models adjusted for covariates to identify factors associated with incomplete vaccination and negative serology after vaccination. Out of the 825 children included in the study, adherence to the vaccine was 90.6% for MMR, 76.7% for the MMRV (MMR + varicella), and 74.9% for the hepatitis A vaccine. For MMR, after the adjustment for covariates, factors associated with incomplete vaccination included: white-skinned mother; paid maternity leave; raising more than one child; lower number of antenatal consultations; and attending childcare. For hepatitis A, the factors included: white-skinned mother and not having a cohabiting partner. The factors with statistically significant association with a negative antibody test result included: receiving Bolsa Familia allowance for measles and mumps; incomplete vaccination for measles; and vitamin A deficiency for mumps. Strategies to improve the efficiency of vaccine programs are urgently needed. These include improvements in communication about vaccine safety and efficacy, and amplification of access to primary care facilities, prioritizing children exposed to the sociodemographic factors identified in this study. Additionally, sociodemographic factors and vitamin A deficiency may impact the immune responses to vaccines, leading to an increased risk of potentially severe and preventable diseases.

5.
Rev. Inst. Med. Trop. Säo Paulo ; 59: e2, 2017. tab, graf
Article in English | LILACS | ID: biblio-842764

ABSTRACT

ABSTRACT Introduction: The World Health Organization (WHO) recommends one single dose of the Yellow Fever (YF) vaccine based on studies of antibody persistency in healthy adults. We assessed the prevalence and titers of YF virus neutralizing antibodies in previously vaccinated persons aged ≥ 60 years, in comparison to younger adults. We also evaluated the correlation between antibody titers and the time since vaccination among participants who received one vaccine dose, and the seropositivity among participants vaccinated prior to or within the past 10 years. Methods: previously vaccinated healthy persons aged ≥ 18 years were included. YF virus neutralizing antibody titers were determined by means of the 50% Plaque Reduction Neutralization Test. Results: 46 persons aged ≥ 60 years and 48 persons aged 18 to 59 years were enrolled. There was no significant difference in the prevalence of YF virus neutralizing antibodies between the two groups (p = 0.263). However, titers were significantly lower in the elderly (p = 0.022). There was no correlation between YF virus neutralizing antibody titers and the time since vaccination. There was no significant difference in seropositivity among participants vaccinated prior to or within the past 10 years. Conclusions: the clinical relevance of the observed difference in YF virus neutralizing antibody titers between the two groups is not clear.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Yellow Fever Vaccine/immunology , Yellow fever virus/immunology , Yellow Fever/prevention & control , Age Factors , Brazil , Immunoglobulin M/blood , Yellow Fever/immunology
6.
Braz. j. infect. dis ; 19(1): 90-93, Jan-Feb/2015. graf
Article in English | LILACS | ID: lil-741230

ABSTRACT

Disseminated infection by Fusarium is a rare, frequently lethal condition in severely immunocompromised patients, including bone marrow transplant recipients. However, autologous bone marrow transplant recipients are not expected to be at high risk to develop fusariosis. We report a rare case of lethal disseminated Fusarium infection in an autologous bone marrow transplant recipient during pre-engraftment phase.


Subject(s)
Humans , Male , Middle Aged , Bone Marrow Transplantation/adverse effects , Fusariosis/pathology , Lymphoma, Follicular/surgery , Fusariosis/diagnosis , Immunocompromised Host , Transplantation, Autologous
7.
Rev. Inst. Med. Trop. Säo Paulo ; 56(5): 417-420, Sep-Oct/2014. tab
Article in English | LILACS | ID: lil-722323

ABSTRACT

Introduction: Vaccination is the main preventive strategy against Yellow Fever (YF), which is a public health concern in Brazil. However, HIV-infected patients might have insufficient knowledge regarding YF, YF prevention, and vaccines in general. Methods: In this questionnaire-based study, data from 158 HIV-infected individuals were addressed in three distinct outpatient clinics in São Paulo. Information was collected on demographic and clinical characteristics, as well as patients' knowledge of vaccines, YF and YF preventive strategies. In addition, individual YF vaccine recommendations and vaccine status were investigated. Results: Although most participants adequately ascertain the vaccine as the main prevention strategy against YF, few participants were aware of the severity and lack of specific treatment for YF. Discrepancy in YF vaccine (patients who should have taken the vaccine, but did not) was observed in 18.8% of participants. Conclusion: YF is an important and preventable public health concern, and these results demonstrate that more information is necessary for the HIV-infected population.


A vacinação é a principal forma de prevenção contra a Febre Amarela (FA), doença de importância em saúde pública no Brasil. Entretanto, pessoas que vivem com HIV possivelmente possuem conhecimentos insuficientes a respeito da FA, suas formas de prevenção e também sobre vacinas de modo geral. Métodos: Neste estudo baseado em questionários de autopreenchimento, avaliamos dados de 158 pacientes infectados por HIV atendidos em três diferentes serviços ambulatoriais do Município de São Paulo. Foram coletados dados demográficos, clínicos, e dados relacionados ao grau de conhecimento a respeito de vacinas, da FA e de suas formas de prevenção. Além disso, avaliamos individualmente a indicação e antecedente de vacinação contra FA. Resultados: Embora a maioria dos participantes tenha identificado corretamente que a vacina é a principal forma de prevenção da FA, poucos tinham conhecimento a respeito da gravidade clínica e ausência de tratamento específico da doença. Discrepância na vacinação (caracterizada quando o participante deveria ter recebido a vacina, mas não a recebeu) foi observada em 18,8% dos casos. Conclusão: A FA é importante agravo em saúde pública, passível de prevenção, e nossos resultados demonstram que são necessárias mais ações de educação voltadas à população de pessoas que vivem com HIV.


Subject(s)
Adolescent , Adult , Female , Humans , Male , Health Knowledge, Attitudes, Practice , HIV Infections , Yellow Fever Vaccine , Yellow Fever/prevention & control , Brazil , Cross-Sectional Studies , Surveys and Questionnaires
10.
Clinics ; 66(12): 2031-2035, 2011. ilus, graf, tab
Article in English | LILACS | ID: lil-608998

ABSTRACT

OBJECTIVES: Population aging raises concerns regarding the increases in the rates of morbidity and mortality that result from influenza and its complications. Although vaccination is the most important tool for preventing influenza, vaccination program among high-risk groups has not reached its predetermined aims in several settings. This study aimed to evaluate the impacts of clinical and demographic factors on vaccine compliance among the elderly in a setting that includes a well-established annual national influenza vaccination campaign. METHODS: This cross-sectional study included 134 elderly patients who were regularly followed in an academic medical institution and who were evaluated for their influenza vaccination uptake within the last five years; in addition, the demographic and clinical characteristics and the reasons for compliance or noncompliance with the vaccination program were investigated. RESULTS: In total, 67.1 percent of the participants received the seasonal influenza vaccine in 2009. Within this vaccinationcompliant group, the most common reason for vaccine uptake was the annual nationwide campaign (52.2 percent; 95 percent CI: 41.4-62.9 percent); compared to the noncompliant group, a higher percentage of compliant patients had been advised by their physician to take the vaccine (58.9 percent vs. 34.1 percent; p,0.01). CONCLUSION: The education of patients and health care professionals along with the implementation of immunization campaigns should be evaluated and considered by health authorities as essential for increasing the success rate of influenza vaccination compliance among the elderly.


Subject(s)
Aged , Female , Humans , Male , Immunization Programs , Influenza Vaccines/administration & dosage , Influenza, Human/prevention & control , Patient Compliance/statistics & numerical data , Counseling , Cross-Sectional Studies , Health Knowledge, Attitudes, Practice , Patient Education as Topic , Socioeconomic Factors
SELECTION OF CITATIONS
SEARCH DETAIL